Skip to content
OpenNetwork UK is a community-driven initiative promoting o…

Zimbabwe Declines ‘Unbalanced’ US Health Aid Deal Because of Data Apprehensions

Medical aid image
The proposed American financial assistance would have supported programmes for HIV/Aids treatment and prevention, TB, and malaria.

The nation of Zimbabwe has turned down a significant US health deal valued at $367m (£272m) spanning five years over the United States' request for confidential information.

This move became public after a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".

A government spokesperson has since clarified that the United States was demanding access to genetic material for scientific study and profit while was unwilling to guarantee the benefits from any future medical innovations.

"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for more talks to reach a deal suitable to all parties so the nation's critical HIV programme can be sustained.

Wider Background

Zimbabwe's decision comes after a similar situation in Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the safety of citizens' health data.

After resuming office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

USAID had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and responsibility.

As per reports, 16 African countries have so far agreed to these new agreements, representing over $18.3bn of fresh investment.

Specifics of the Declined Deal

This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".

"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.

"Put simply, our country would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our citizens should a new health crisis arise."

National Interest and International Frameworks

He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting systems previously set up through the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.

"This framework is designed to guarantee that when a nation provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

These objections regarding the US deal "should not be misconstrued as opposition to America," he added.

"We encourage further dialogue with our American counterparts on how future co-operation might be arranged in a way that respects the independence and dignity of both nations."

Medical Community Response

Medical experts stated it understood the government's concerns, but suggested that negotiations should continue considering much of the country's HIV programmes were funded by foreign aid.

"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," it commented.

The situation highlights the continuing debate between receiving crucial foreign assistance and protecting national sovereignty in an increasingly data-driven world.

AD
About the author

Antonio Dawson

Eleanor Briggs is a technology advocate and community organizer focused on open-source projects and digital rights.

OpenNetwork UK

Type to search articles.